A bill to provide that a risk evaluation and mitigation strategy communication plan may include information about Federal and State prescribing requirements for controlled substances.
Reducing Opioid Risk Act
This bill amends the Federal Food, Drug, and Cosmetic Act to expand the authority of the Food and Drug Administration to require a drug manufacturer to inform health care providers about state and federal regulations for controlled substances, including the partial fill option.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 398.
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line